Additionally, the 36-month beta value for OPRX is 1.34. There are mixed opinions on the stock, with 4 analysts rating it as a “buy”, 2 rating it as “overweight”, 1 rating it as “hold”, and 0 rating it as “sell”.
The public float for OPRX is 16.75M and currently, short sellers hold a 9.37% ratio of that float. The average trading volume of OPRX on July 04, 2025 was 292.59K shares.
OPRX stock’s latest price update
The stock of OptimizeRx Corp (NASDAQ: OPRX) has increased by 2.36% when compared to last closing price of $13.12.Despite this, the company has seen a gain of 6.17% in its stock price over the last five trading days. zacks.com reported 2025-07-03 that OPRX surged 69.3% in three months as rising contracted revenue and subscription gains boost confidence and guidance.
OPRX’s Market Performance
OptimizeRx Corp (OPRX) has experienced a 6.17% rise in stock performance for the past week, with a 1.59% rise in the past month, and a 61.22% rise in the past quarter. The volatility ratio for the week is 5.11%, and the volatility levels for the past 30 days are at 6.52% for OPRX. The simple moving average for the past 20 days is -2.56% for OPRX’s stock, with a 75.82% simple moving average for the past 200 days.
Analysts’ Opinion of OPRX
Many brokerage firms have already submitted their reports for OPRX stocks, with RBC Capital Mkts repeating the rating for OPRX by listing it as a “Sector Perform”. The predicted price for OPRX in the upcoming period, according to RBC Capital Mkts is $6 based on the research report published on January 08, 2025 of the current year 2025.
Stephens, on the other hand, stated in their research note that they expect to see OPRX reach a price target of $5.50. The rating they have provided for OPRX stocks is “Equal-Weight” according to the report published on December 20th, 2024.
JMP Securities gave a rating of “Mkt Outperform” to OPRX, setting the target price at $15 in the report published on April 04th of the previous year.
OPRX Trading at 12.58% from the 50-Day Moving Average
After a stumble in the market that brought OPRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -14.51% of loss for the given period.
Volatility was left at 6.52%, however, over the last 30 days, the volatility rate increased by 5.11%, as shares sank -2.54% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +63.78% upper at present.
During the last 5 trading sessions, OPRX rose by +6.17%, which changed the moving average for the period of 200-days by +72.18% in comparison to the 20-day moving average, which settled at $13.78. In addition, OptimizeRx Corp saw 34.43% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OPRX starting from Lang James Paul, who purchase 321,408 shares at the price of $7.60 back on Mar 14 ’25. After this action, Lang James Paul now owns 389,452 shares of OptimizeRx Corp, valued at $2,443,761 using the latest closing price.
FEBBO WILLIAM J, the CEO of OptimizeRx Corp, purchase 20,000 shares at $5.01 during a trade that took place back on Dec 12 ’24, which means that FEBBO WILLIAM J is holding 601,253 shares at $100,220 based on the most recent closing price.
Stock Fundamentals for OPRX
Current profitability levels for the company are sitting at:
- -0.11% for the present operating margin
- 0.63% for the gross margin
The net margin for OptimizeRx Corp stands at -0.16%. The total capital return value is set at -0.07%. Equity return is now at value -12.90%, with -8.95% for asset returns.
Based on OptimizeRx Corp (OPRX), the company’s capital structure generated 0.22 points at debt to capital in total, while cash flow to debt ratio is standing at 0.2. The debt to equity ratio resting at 0.28. The interest coverage ratio of the stock is -1.83.
Currently, EBITDA for the company is -8.9 million with net debt to EBITDA at -2.59. When we switch over and look at the enterprise to sales, we see a ratio of 2.8. The receivables turnover for the company is 2.88for trailing twelve months and the total asset turnover is 0.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.82.
Conclusion
In conclusion, OptimizeRx Corp (OPRX) has seen better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
